Onconic Therapeutics Inc. (KOSDAQ:476060)

Onconic Therapeutics Statistics

Total Valuation

KOSDAQ:476060 has a market cap or net worth of KRW 734.53 billion. The enterprise value is 681.11 billion.

Market Cap	734.53B
Enterprise Value	681.11B

Important Dates

The last earnings date was Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:476060 has 44.49 million shares outstanding.

Current Share Class	44.49M
Shares Outstanding	44.49M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-74.81%
Owned by Insiders (%)	1.84%
Owned by Institutions (%)	7.05%
Float	20.86M

Valuation Ratios

The trailing PE ratio is 10.91.

PE Ratio	10.91
Forward PE	n/a
PS Ratio	15.75
PB Ratio	10.66
P/TBV Ratio	10.66
P/FCF Ratio	103.72
P/OCF Ratio	100.71
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 52.67, with an EV/FCF ratio of 96.17.

EV / Earnings	40.65
EV / Sales	14.60
EV / EBITDA	52.67
EV / EBIT	55.04
EV / FCF	96.17

Financial Position

The company has a current ratio of 13.21, with a Debt / Equity ratio of 0.00.

Current Ratio	13.21
Quick Ratio	12.64
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.02
Interest Coverage	880.74

Financial Efficiency

Return on equity (ROE) is 33.75% and return on invested capital (ROIC) is 15.50%.

Return on Equity (ROE)	33.75%
Return on Assets (ROA)	14.36%
Return on Invested Capital (ROIC)	15.50%
Return on Capital Employed (ROCE)	17.95%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.87
Inventory Turnover	n/a

Taxes

Income Tax	-2.25B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	16,843.40
200-Day Moving Average	8,693.34
Relative Strength Index (RSI)	47.24
Average Volume (20 Days)	5,083,115

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:476060 had revenue of KRW 46.65 billion and earned 16.75 billion in profits. Earnings per share was 1,513.84.

Revenue	46.65B
Gross Profit	46.64B
Operating Income	12.37B
Pretax Income	14.50B
Net Income	16.75B
EBITDA	12.93B
EBIT	12.37B
Earnings Per Share (EPS)	1,513.84

Balance Sheet

The company has 53.59 billion in cash and 172.37 million in debt, giving a net cash position of 53.41 billion or 1,200.59 per share.

Cash & Cash Equivalents	53.59B
Total Debt	172.37M
Net Cash	53.41B
Net Cash Per Share	1,200.59
Equity (Book Value)	68.88B
Book Value Per Share	6,198.95
Working Capital	60.47B

Cash Flow

In the last 12 months, operating cash flow was 7.29 billion and capital expenditures -211.35 million, giving a free cash flow of 7.08 billion.

Operating Cash Flow	7.29B
Capital Expenditures	-211.35M
Free Cash Flow	7.08B
FCF Per Share	159.18

Margins

Gross margin is 99.97%, with operating and profit margins of 26.53% and 35.91%.

Gross Margin	99.97%
Operating Margin	26.53%
Pretax Margin	31.08%
Profit Margin	35.91%
EBITDA Margin	27.72%
EBIT Margin	26.53%
FCF Margin	15.18%

Dividends & Yields

KOSDAQ:476060 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.28%
FCF Yield	0.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 10, 2025. It was a forward split with a ratio of 4.

Last Split Date	Oct 10, 2025
Split Type	Forward
Split Ratio	4

Scores

KOSDAQ:476060 has an Altman Z-Score of 32.91 and a Piotroski F-Score of 4.

Altman Z-Score	32.91
Piotroski F-Score	4